India allows emergency use of two vaccines for U-12 children
Drugs Controller General of India (DCGI) authorized the emergency use of two Covid-19 vaccines for children under the age of […]
Say something
Covaxin 77.8% effective against Covid-19 – Lancet Study
Bharat Biotech’s Covaxin has showcased 77.8 per cent efficacy against symptomatic Covid-19 and presents no safety concerns as detailed by […]
UK government to add Covaxin to approved list of vaccines from 22 November
Bharat Biotech’s Covaxin will be added to the UK government’s list of approved vaccines from 22 November. Passengers having taken […]
Emergency use approval granted to Bharat Biotech Covaxin for kids aged 2-18 years
In a major step to further the expanse of the vaccination drive in the country, Subject Expert Committee (SEC) of […]
IVI, Bharat Biotech Begin Chikungunya Vaccine Phase-II/III Trials in Costa Rica
The International Vaccine Institute or IVI and Bharat Biotech International Ltd or BBIL have begun the phase-II /III trials of […]
Govt is Supporting Augmentation of Bharat Biotech, 3 PSEs for Boosting Covaxin Production: Union Minister Mansukh Mandaviya
The manufacturing cost of medicine or vaccine is dependent on factors such as development cost, Intellectual Property Rights (IPR) cost, […]
Bharat Biotech Gets GMP Certificate from Hungary
Covaxin, the Covid-19 vaccine of Bharat Biotech International Ltd’s (BBIL), has obtained Hungary’s Good Manufacturing Practices or GMP compliance certificate. […]
Bharat Biotech International Terminated Covaxin MoU with Brazilian Precisa Medicamentos
Hyderabad-headquartered Bharat Biotech International Ltd (BBIL) has reportedly terminated an MoU (Memorandum of Understanding) of selling its Covid vaccine Covaxin […]
Bharat Biotech’s Covaxin Partner Ocugen Looks for Approval in Canada
Bharat Biotech International Ltd’s (BBIL) Covaxin partner for the US and Canada Ocugen Inc has started a rolling submission to […]
Bharat Biotech Submits Documents to WHO for Covaxin’s EUL Listing
Hyderabad-headquartered Bharat Biotech International Ltd (BBIL) has reportedly submitted all documents required for Emergency Use Listing or EUL of the […]
Bharat Biotech Expands Covaxin Production to 50 crore Doses a Year
Bharat Biotech International Ltd (BBIL), the Hyderabad-headquartered vaccine manufacturer has augmented its Covaxin-producing capacity to 500 million (50 crores) doses […]
Bharat Biotech Dispatches Covaxin Covid-19 Vaccine to These States
Hyderabad’s Bharat Biotech has said that it has dispatched Covaxin Covid-19 vaccine to many states such as Assam, Uttarakhand, Tamil […]
Bharat Biotech Supplies Covaxin Directly to 14 Worst-hit States
Hyderabad-based Bharat Biotech has reportedly said that it has supplied the vaccine to 14 worst-hit states, including Maharashtra, Delhi, and […]
-
-
Flipkart Health+ App Launched
06-04-2022
